BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24005562)

  • 1. Assessment of aggressiveness of rectal cancer using 3-T MRI: correlation between the apparent diffusion coefficient as a potential imaging biomarker and histologic prognostic factors.
    Akashi M; Nakahusa Y; Yakabe T; Egashira Y; Koga Y; Sumi K; Noshiro H; Irie H; Tokunaga O; Miyazaki K
    Acta Radiol; 2014 Jun; 55(5):524-31. PubMed ID: 24005562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness.
    Curvo-Semedo L; Lambregts DM; Maas M; Beets GL; Caseiro-Alves F; Beets-Tan RG
    J Magn Reson Imaging; 2012 Jun; 35(6):1365-71. PubMed ID: 22271382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extramural depth of tumor invasion at thin-section MR in rectal cancer: associating with prognostic factors and ADC value.
    Tong T; Yao Z; Xu L; Cai S; Bi R; Xin C; Gu Y; Peng W
    J Magn Reson Imaging; 2014 Sep; 40(3):738-44. PubMed ID: 24307597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer.
    Elmi A; Hedgire SS; Covarrubias D; Abtahi SM; Hahn PF; Harisinghani M
    Clin Radiol; 2013 Oct; 68(10):e524-31. PubMed ID: 23830776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
    Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging.
    Kremser C; Judmaier W; Hein P; Griebel J; Lukas P; de Vries A
    Strahlenther Onkol; 2003 Sep; 179(9):641-9. PubMed ID: 14628131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary value of pre-treatment apparent diffusion coefficient in rectal cancer for predicting tumor recurrence.
    Moon SJ; Cho SH; Kim GC; Kim WH; Kim HJ; Shin KM; Lee SM; Park JS; Choi GS; Kim SH
    Abdom Radiol (NY); 2016 Jul; 41(7):1237-44. PubMed ID: 26830420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.
    Jung SH; Heo SH; Kim JW; Jeong YY; Shin SS; Soung MG; Kim HR; Kang HK
    J Magn Reson Imaging; 2012 Jan; 35(1):110-6. PubMed ID: 21989997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-Weighted Magnetic Resonance Imaging of 103 Patients with Rectal Adenocarcinoma Identifies the Apparent Diffusion Coefficient as an Imaging Marker for Tumor Invasion and Regional Lymph Node Involvement.
    Kargol J; Rudnicki W; Kenig J; Filipowska J; Kaznowska E; Kluz T; Guz W; Łuczyńska E
    Med Sci Monit; 2021 Dec; 27():e934941. PubMed ID: 34871292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy.
    Barbaro B; Vitale R; Valentini V; Illuminati S; Vecchio FM; Rizzo G; Gambacorta MA; Coco C; Crucitti A; Persiani R; Sofo L; Bonomo L
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):594-9. PubMed ID: 22099033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness.
    Sevcenco S; Ponhold L; Heinz-Peer G; Fajkovic H; Haitel A; Susani M; Shariat SF; Szarvas T; Baltzer PA
    Urol Oncol; 2014 Nov; 32(8):1166-71. PubMed ID: 24962659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy.
    Kim SH; Lee JM; Hong SH; Kim GH; Lee JY; Han JK; Choi BI
    Radiology; 2009 Oct; 253(1):116-25. PubMed ID: 19789256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy.
    Park MJ; Kim SH; Lee SJ; Jang KM; Rhim H
    Radiology; 2011 Sep; 260(3):771-80. PubMed ID: 21846762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study.
    Genovesi D; Filippone A; Ausili Cèfaro G; Trignani M; Vinciguerra A; Augurio A; Di Tommaso M; Borzillo V; Sabatino F; Innocenti P; Liberatore E; Colecchia G; Tartaro A; Cotroneo AR
    Eur J Surg Oncol; 2013 Oct; 39(10):1071-8. PubMed ID: 23953231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal cancer staging: Multidetector-row computed tomography diagnostic accuracy in assessment of mesorectal fascia invasion.
    Ippolito D; Drago SG; Franzesi CT; Fior D; Sironi S
    World J Gastroenterol; 2016 May; 22(20):4891-900. PubMed ID: 27239115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of diffusion-weighted-MRI in prostate cancer.
    Wibulpolprasert P; Phongkitkarun S; Chalermsanyakorn P
    J Med Assoc Thai; 2013 Aug; 96(8):967-75. PubMed ID: 23991605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are ADC values of readout-segmented echo-planar diffusion-weighted imaging (RESOLVE) correlated with pathological prognostic factors in rectal adenocarcinoma?
    Tang C; Lin MB; Xu JL; Zhang LH; Zuo XM; Zhang ZS; Liu MX; Xu JM
    World J Surg Oncol; 2018 Jul; 16(1):138. PubMed ID: 30001205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring the apparent diffusion coefficient in primary rectal tumors: is there a benefit in performing histogram analyses?
    van Heeswijk MM; Lambregts DMJ; Maas M; Lahaye MJ; Ayas Z; Slenter JMGM; Beets GL; Bakers FCH; Beets-Tan RGH
    Abdom Radiol (NY); 2017 Jun; 42(6):1627-1636. PubMed ID: 28160039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.